RHUMBLINE ADVISERS - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 59 filers reported holding UTAH MED PRODS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$397,578
-5.2%
4,623
+2.8%
0.00%
Q2 2023$419,306
+96514.3%
4,499
-1.8%
0.00%
-100.0%
Q1 2023$434
-4.0%
4,583
+1.8%
0.00%0.0%
Q4 2022$452
-99.9%
4,501
+2.6%
0.00%0.0%
Q3 2022$374,000
+5.9%
4,389
+6.7%
0.00%0.0%
Q2 2022$353,000
-14.5%
4,114
-10.6%
0.00%0.0%
Q1 2022$413,000
-17.2%
4,601
-7.9%
0.00%0.0%
Q4 2021$499,000
+6.6%
4,994
-1.0%
0.00%0.0%
Q3 2021$468,000
+13.0%
5,046
+3.6%
0.00%0.0%
Q2 2021$414,000
+7.3%
4,871
+9.2%
0.00%0.0%
Q1 2021$386,000
-0.8%
4,460
-3.3%
0.00%0.0%
Q4 2020$389,000
+14.4%
4,610
+8.2%
0.00%0.0%
Q3 2020$340,000
-21.5%
4,259
-12.8%
0.00%0.0%
Q2 2020$433,000
-3.3%
4,883
+2.4%
0.00%0.0%
Q1 2020$448,000
-12.8%
4,7680.0%0.00%0.0%
Q4 2019$514,000
+13.2%
4,768
+0.7%
0.00%0.0%
Q3 2019$454,000
+1.8%
4,733
+1.5%
0.00%0.0%
Q2 2019$446,000
+8.3%
4,665
-0.1%
0.00%0.0%
Q1 2019$412,000
+6.7%
4,672
+0.7%
0.00%0.0%
Q4 2018$386,000
+33.6%
4,641
+51.4%
0.00%0.0%
Q3 2018$289,000
-19.7%
3,065
-6.1%
0.00%0.0%
Q2 2018$360,000
+16.5%
3,265
+4.3%
0.00%0.0%
Q1 2018$309,000
+18.4%
3,129
-2.5%
0.00%0.0%
Q4 2017$261,000
-6.8%
3,209
-15.8%
0.00%0.0%
Q3 2017$280,000
-0.4%
3,811
-1.8%
0.00%0.0%
Q2 2017$281,000
+4.9%
3,881
-9.9%
0.00%0.0%
Q1 2017$268,000
-11.3%
4,306
+3.8%
0.00%0.0%
Q4 2016$302,000
+7.5%
4,149
-11.6%
0.00%0.0%
Q3 2016$281,000
-2.8%
4,695
+2.2%
0.00%0.0%
Q2 2016$289,000
+16.1%
4,595
+15.6%
0.00%0.0%
Q1 2016$249,000
+10.7%
3,974
+3.2%
0.00%0.0%
Q4 2015$225,000
+8.7%
3,849
+10.9%
0.00%0.0%
Q2 2015$207,000
-5.9%
3,470
-5.4%
0.00%0.0%
Q1 2015$220,0003,6700.00%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2015
NameSharesValueWeighting ↓
HealthInvest Partners AB 40,000$4,000,0005.64%
Clean Yield Group 14,474$1,447,0000.46%
RICE HALL JAMES & ASSOCIATES, LLC 113,833$11,383,0000.40%
Ranger Investment Management 68,730$6,873,0000.38%
ISTHMUS PARTNERS, LLC 17,534$1,753,0000.29%
Cardinal Capital Management 10,097$1,010,0000.20%
GLOBEFLEX CAPITAL L P 19,420$1,942,0000.20%
Ancora Advisors LLC 26,689$2,669,0000.06%
Penobscot Investment Management Company, Inc. 4,000$400,0000.05%
SEIZERT CAPITAL PARTNERS, LLC 10,430$1,043,0000.05%
View complete list of UTAH MED PRODS INC shareholders